Affimed NV (AFMD)
3.65
-0.08
(-2.28%)
USD |
NASDAQ |
Nov 14, 16:00
3.65
0.00 (0.00%)
After-Hours: 18:04
Affimed Total Liabilities (Quarterly): 26.22M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 26.22M |
| March 31, 2024 | 32.28M |
| December 31, 2023 | 43.50M |
| September 30, 2023 | 46.62M |
| June 30, 2023 | 38.89M |
| March 31, 2023 | 46.74M |
| December 31, 2022 | 51.04M |
| September 30, 2022 | 54.35M |
| June 30, 2022 | 71.12M |
| March 31, 2022 | 84.64M |
| December 31, 2021 | 100.98M |
| September 30, 2021 | 100.31M |
| June 30, 2021 | 115.60M |
| March 31, 2021 | 119.28M |
| December 31, 2020 | 127.59M |
| September 30, 2020 | 71.53M |
| June 30, 2020 | 68.21M |
| March 31, 2020 | 72.61M |
| December 31, 2019 | 82.55M |
| September 30, 2019 | 69.28M |
| June 30, 2019 | 75.35M |
| March 31, 2019 | 76.01M |
| Date | Value |
|---|---|
| December 31, 2018 | 86.99M |
| September 30, 2018 | 15.36M |
| June 30, 2018 | 14.26M |
| March 31, 2018 | 15.20M |
| December 31, 2017 | 13.89M |
| September 30, 2017 | 13.61M |
| June 30, 2017 | 14.97M |
| March 31, 2017 | 10.10M |
| December 31, 2016 | 10.56M |
| September 30, 2016 | 11.26M |
| June 30, 2016 | 10.10M |
| March 31, 2016 | 12.29M |
| December 31, 2015 | 13.17M |
| September 30, 2015 | 10.59M |
| June 30, 2015 | 10.62M |
| March 31, 2015 | 9.353M |
| December 31, 2014 | 12.30M |
| September 30, 2014 | 12.79M |
| June 30, 2014 | 144.65M |
| March 31, 2014 | 167.67M |
| December 31, 2013 | 145.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
26.22M
Minimum
Jun 2024
127.59M
Maximum
Dec 2020
71.26M
Average
71.12M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| InflaRx NV | 11.66M |
| BioNTech SE | 3.671B |
| Immatics NV | 256.27M |
| CureVac NV | 193.27M |
| ATAI Life Sciences NV | 47.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 57.00M |
| Shareholders Equity (Quarterly) | 30.78M |
| Debt to Equity Ratio | 0.3286 |
| Current Ratio | 2.710 |
| Net Debt Paydown Yield | 1.79% |